Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Quarterly results
INOVIO PHARMACEUTICALS, INC. (INO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
08/09/2023 8-K Quarterly results
Docs: "INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
07/10/2023 SC 13G/A STATE STREET CORP reports a 0.3% stake in EXIT FILING INOVIO PHARMACEUTICALS INC
07/07/2023 SC 13G/A BlackRock Inc. reports a 2.3% stake in INOVIO PHARMACEUTICALS INC
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Inovio Pharmaceuticals, Inc. 2023 Omnibus Incentive Plan",
"Inovio Pharmaceuticals, Inc. 2023 Omnibus Incentive Plan"
05/17/2023 4 Sumner Michael John (Chief Medical Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Granted 85,878 restricted stock units @ $0
05/17/2023 4 Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Granted 171,756 restricted stock units @ $0
05/17/2023 4 KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Granted 171,756 restricted stock units @ $0
05/17/2023 4 Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Granted 638,800 restricted stock units @ $0
05/16/2023 4 Zoth Lota S. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 YARNO WENDY L (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 BENITO SIMON X (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 Miller Ann Calby (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 19,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
05/16/2023 4 DANSEY ROGER D (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Exercised 12,000 restricted stock units @ $0
Granted 35,000 options @ $0.77, valued at $27k
Granted 26,000 restricted stock units @ $0
Exercised 19,000 restricted stock units @ $0
05/12/2023 4 Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 28,704 shares @ $0.81, valued at $23.3k
Exercised 66,000 restricted stock units @ $0
05/10/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights"
04/04/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/28/2023 ARS Form ARS - Annual Report to Security Holders:
03/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 POS EX Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
03/13/2023 4 Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Sold 5,833 shares @ $1.15, valued at $6.7k
Exercised 11,666 restricted stock units @ $0
03/13/2023 4 Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 20,658 shares @ $1.13, valued at $23.3k
Exercised 59,737 restricted stock units @ $0
03/13/2023 4 Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 25,980 shares @ $1.13, valued at $29.4k
Exercised 59,737 restricted stock units @ $0
03/13/2023 4 KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 31,410 shares @ $1.13, valued at $35.5k
Exercised 59,737 restricted stock units @ $0
03/01/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/01/2023 10-K Annual Report for the period ended December 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy